Main Page Article Search E-Lerts™ Newsletter: Current E-Lerts™ Newsletter Archives E-Lerts™ Newsletter Recipes Archives Defeat Diabetes® E-Lerts™ Newsletter Subscribe Defeat Diabetes ® News by Daniel H. Rasolt Books You Can Use™ Subscribe to Defeat Diabetes Foundation Mailings
About Diabetes Body Care Children Complications Defeat Diabetes Foundation Drugs    » ACE Inhibitor    » Actos    » Alternative Medicine    » Aspirin    » Avandia    » Byetta    » Drugs    » Exenatide    » Glargine    » Glucophage    » Insulin    » Januvia    » Lantus    » Liraglutide    » Metformin    » Recall    » Research    » Rosiglitazone    » Self-Management    » Statins    » Sulfonylureas    » Victoza Elderly E-Lerts™ Governments & Organizations Health & Fitness Insulin MADDCAP™ Mr. Diabetes® Nutrition Obesity Other Diseases Pregnancy Research Risks Self-Management Supplements Type 1 Warning Signs

 

 

 

     

Drugs » Drugs

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

'Good' Cholesterol Raised by Experimental Drug, May Impact Diabetes Control Posted: Saturday, July 23, 2011

A medicine designed to improve levels of "good" cholesterol may also help control blood sugar in people with diabetes who are taking cholesterol-lowering drugs.

Sitagliptin Shows Anti-inflammatory Activity in Diabetes Patients Posted: Wednesday, July 20, 2011

The dipeptidyl peptidase (DPP)-4 inhibitor sitagliptin exerts an anti-inflammatory effect in patients with type 2 diabetes at the cellular and molecular level.

Lilly Prepares to Launch Bydureon in US Posted: Wednesday, July 20, 2011

Eli Lilly aims to bring its once-a-week diabetes injection Bydureon to US markets in the first half of next year.

Is Inhaled Insulin Closer to Reality? Posted: Monday, July 11, 2011

New data on the inhalable insulin product Technosphere Insulin Afrezza, from MannKind Corp., indicate that the treatment confers no discernible risk for increased cardiovascular (CV) events, while another study examined patient satisfaction with this type of drug.

Vascular Status Predicts Hypoglycemia Posted: Tuesday, July 05, 2011

Type 2 diabetes patients with microvascular or macrovascular complications, or those taking certain monotherapies, are more likely to experience hypoglycemia and require outpatient hospital visits.

HbA1C Test Poorly Predictive in Dialysis Patients Posted: Saturday, June 11, 2011

Conventional glucose control monitoring methods may not be as meaningful in diabetes patients with end-stage renal disease, researchers found. Patients on dialysis will normally show a lower A1c than they actually have, giving patients and physicians a false sense of security.

Young Diabetes Patients Using Oral Antidiabetics and Insulin at Higher Risk of Depression Posted: Sunday, June 05, 2011

The risk of depression among patients with diabetes varies depending on age and type of diabetes according to new research.

Combining Paxil and Pravachol Can Raise Blood Sugar Posted: Sunday, June 05, 2011

Combining two drugs commonly prescribed to treat depression and lower cholesterol can raise blood sugar to potentially harmful levels, according to a study released this week that was based partly on a search of computerized patient records at Boston-area hospitals.

Diabetes Drug Victoza Could Combat Dementia Posted: Sunday, June 05, 2011

Dr. Christian Holscher and his University of Ulster, Northern Ireland, UK, team have already found the drug can enhance brain cell growth and protect memory formation in mice, as well as reducing levels of amyloid -- a hallmark protein in Alzheimer's -- in the brain.

Low-Dose Aspirin Helps Heart Only in Some Diabetes Patients Posted: Monday, May 30, 2011

Low-dose aspirin is predominantly of value in reducing atherosclerotic events in patients with less advanced diabetes.

 

 

 

 

 

 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.